Saturday 17 October 2026 Export OMCL’s income statement to Excel — free account

Omnicell, Inc.

OMCL Healthcare Health Information Services

Omnicell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 6.53% from fiscal 2024. In the quarter to June 2026, revenue grew 7.45%, EPS grew 341.7%, free cash flow grew 107.9% and total debt fell 50.8%, each against the same quarter a year earlier.

35.39 0.56 −1.56%

Follow OMCL

Alert me

Market cap: $1.6B
P/E: 41.6×
Fwd P/E: 55.1×
Dividend yield: —
F-score: 7/9
Altman Z: 2.69
Beneish M: −2.85
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Omnicell, Inc. (OMCL) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Omnicell, Inc. (OMCL) trades at a P/E ratio of 41.6×. Over the past ten years it has ranged from 0.0× (December 2024) to 1,285× (January 2026); the current reading is higher than 28% of that period. That is in line with the Health Information Services industry median of 39.8× and above the Healthcare sector median of 23.0×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/OMCL/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Omnicell, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/OMCL/metrics/pe-ratio">Omnicell, Inc. (OMCL) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	1,133×	586.83%
FY2024	165×	—
FY2023	0.0×	—
FY2022	368×	265.20%
FY2021	101×	(35.33%)
FY2020	156×	182.29%
FY2019	55.2×	(13.44%)
FY2018	63.8×	(26.48%)
FY2017	86.8×	(32.40%)
FY2016	128×	255.17%

Period	P/E ratio	Change
Jun 2026	48.8×	(35.61%)
Mar 2026	75.9×	(93.30%)
Dec 2025	1,133×	1,499.26%
Sep 2025	70.8×	20.43%
42 more quarters	Free account

Against its own ten years

Low 0.0× High 1,285×

Ten-year median 61.8×

Current reading's percentile 7

Company	P/E ratio
TDOC Teladoc Health, Inc. compare	n/m
SDGR Schrodinger, Inc. compare	n/m
CERT Certara, Inc. compare	n/m
OMCL Omnicell, Inc.	41.6×
HSTM HealthStream, Inc. compare	46.0×
GDRX GoodRx Holdings, Inc. compare	62.7×
PHR Phreesia, Inc. compare	64.4×
PRVA Privia Health Group, Inc. compare	102×
OMDA Omada Health, Inc. compare	252×
Health Information Services industry median	39.8×
Healthcare sector median	23.0×
Market median	18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Omnicell, Inc. (OMCL) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on OMCL

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on OMCL

Stockrow Weekly